Jefferies downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Buy to Hold with a price target of $24.00 (from $61.00).Analyst Eun K ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE